BMS staff benefit NHS in bowel cancer care
A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists, active in 95% of patient pathways
A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists, active in 95% of patient pathways
End-to-end workflow analyzes safety, purity and potency of cannabis to help meet Health Canada's testing standards
Company also receives new FDA emergency use authorizations for use of self-collection molecular diagnostic kit on the Hologic and Roche platforms
Process Monitoring and Analysis in Biofuel Workflows
Broad Scope Pesticide Screening in Food Using Triple Quadrupole GC-MS
"Smaller, simpler, and easier to use – without compromising performance." That’s the demand from analysts. And that’s why Shimadzu developed the Brevis GC-2050.

The Tumor Tissue Modified Viral (TTMV)-HPV DNA blood test aids in the detection of HPV-driven cancer
Experienced commercial leader to lead strategic expansion of Cresset's molecular modeling expertise and solutions
Added U.S. capacity will ensure domestic customers vital sources of critical laboratory disposables.
Enables rapid purification of exosomes from blood and other samples